Back to search

Article

Extracellular Vesicles as Biomarkers for Steatosis Stages in MASLD Patients: an Algorithmic Approach Using Explainable Artificial Intelligence

2024-11-30

Abstract excerpt

<h4>Background & Aims</h4> Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as NAFLD, is a leading cause of chronic liver disease worldwide. Current diagnostic methods, including liver biopsies, are invasive and have significant limitations, emphasizing the need for non-invasive alternatives. This study aimed to evaluate extracellular vesicles (EV) as biomarkers for diagnosing and s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4acd071c-e1ca-5d4d-8a0e-6a9972785e42
DOI
10.1101/2024.11.30.24318233
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Extracellular Vesicles as Biomarkers for Steatosis Stages in MASLD Patients: an Algorithmic Approach Using Explainable Artificial IntelligenceDOI 10.1101/2024.11.30.24318233
Select a neighboring publication to make it the new centre.